CELL SURFACE ACTIVITIES IN LIPOPROTEIN CATABOLISM
脂蛋白分解代谢中的细胞表面活性
基本信息
- 批准号:6193760
- 负责人:
- 金额:$ 2.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-18 至 2000-11-30
- 项目状态:已结题
- 来源:
- 关键词:adipocytes blood lipoprotein metabolism blood lipoprotein transport cell differentiation genetic promoter element genetic regulatory element heparan sulfate laboratory mouse laboratory rabbit lipase low density lipoprotein receptor proteoglycan receptor binding receptor expression receptor mediated endocytosis transcription factor
项目摘要
DESCRIPTION(adapted from applicant's abstract): Studies in this application
propose to investigate this apparent synergistic relationship between HSPG and
LRP or megalin, that is necessary for lipoprotein/lipase clearance by cells.
Using quantitative biochemical procedures we will determine if ligands are 1)
transferred to the endocytic receptors for internalization following their
initial binding to HSPG, or 2) if the HSPG and endocytic receptors are
cointernalized with bound ligand. These studies will aid in determining if LRP
and megalin can regulate ligand sequestration or lipolytic enzyme activities by
controlling the amount of HSPG that is present on the cell surface through
endocytosis. We also plan to identify the proteoglycan-like molecule that
coprecipitates with megalin and LRP, and determine if disrupting its
interactions with LRP and megalin prevents the uptake of lipoproteins by cells.
As a second goal, studies are proposed to quantitatively evaluate the changes
in LRP and megalin expression during adipocyte differentiation, and assess the
functional role of these receptors in intracellular lipid accumulation.
Supporting data have found that expression of LRP and megalin in
differentiating adipocytes is responsive to glucocorticoid- and cAMP-dependent
signaling pathways. Based on this observation the applicant plans to identify
and characterize the cis- and trans-activating elements in the promoters of LRP
and megalin that are responsible for regulating their expression levels during
adipocyte development. Together, these studies will help 1) better define the
functional roles of LRP and megalin in lipoprotein clearance, 2) begin to
understand the molecular basis of their tissue-specific expression, and 3)
advance our knowledge of cardiovascular health and disease such as
atherosclerosis and obesity.
描述(改编自申请人摘要):本申请的研究
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Anthony Orlando其他文献
Robert Anthony Orlando的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Anthony Orlando', 18)}}的其他基金
Curcumin-based analogs as improved inhibitors of Abeta aggregation
基于姜黄素的类似物作为改进的 Abeta 聚集抑制剂
- 批准号:
7196922 - 财政年份:2007
- 资助金额:
$ 2.25万 - 项目类别:
Curcumin-based analogs as improved inhibitors of Abeta aggregation
基于姜黄素的类似物作为改进的 Abeta 聚集抑制剂
- 批准号:
7342015 - 财政年份:2007
- 资助金额:
$ 2.25万 - 项目类别:
CELL SURFACE ACTIVITIES IN LIPOPROTEIN CATABOLISM
脂蛋白分解代谢中的细胞表面活性
- 批准号:
6620164 - 财政年份:2000
- 资助金额:
$ 2.25万 - 项目类别:
CELL SURFACE ACTIVITIES IN LIPOPROTEIN CATABOLISM
脂蛋白分解代谢中的细胞表面活性
- 批准号:
6390483 - 财政年份:2000
- 资助金额:
$ 2.25万 - 项目类别:
CELL SURFACE ACTIVITIES IN LIPOPROTEIN CATABOLISM
脂蛋白分解代谢中的细胞表面活性
- 批准号:
6442866 - 财政年份:2000
- 资助金额:
$ 2.25万 - 项目类别:
INTERACTIONS OF THE GP330/44 ANTIGENIC COMPLEX
GP330/44 抗原复合物的相互作用
- 批准号:
2135775 - 财政年份:1994
- 资助金额:
$ 2.25万 - 项目类别:
INTERACTIONS OF THE GP330/44 ANTIGENIC COMPLEX
GP330/44 抗原复合物的相互作用
- 批准号:
2135774 - 财政年份:1993
- 资助金额:
$ 2.25万 - 项目类别: